Calcineurin Inhibitors: all 995 studies that test it
Page 5 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and LeukemiaWithdrawnNCT04961801Phase 1/2
- Comparison of Safety and Efficacy of de Novo EverolimusCompletedNCT04906304Not applicable
- Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of LifeCompletedNCT04900948Phase 4
- NMF-CsA-Dupi TrialStatus unknownNCT04878770Not applicable
- CEQUA for Sjogren's Syndrome Dry EyeCompletedNCT04835623Phase 4
- Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in SingaporeCompletedNCT04825262Not applicable
- Cyclosporine on Day Zero as Prophylaxis for Cytokine Release SyndromeStatus unknownNCT04781803Phase 2
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
- A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)Status unknownNCT04775303Phase 4
- Evaluate the Efficacy and Safety of the ADVAGRAF®CompletedNCT04763096Phase 4
- To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant RecipientsCompletedNCT04761731Phase 4
- The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
- Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMNTerminatedNCT04743739Phase 3
- Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant RecipientsActive, not recruitingNCT04720326Phase 4
- Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical StudyCompletedNCT04714099Phase 3
- Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney TransplantActive, not recruitingNCT04665310Phase 4
- Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT04646356Phase 2
- The Study of Pharmacokinetic Interactions Between HL237 and TacrolimusStatus unknownNCT04633733Phase 1
- Effect of Ciclosporin Eyedrops on Sjögren SyndromeCompletedNCT04597762Not applicable
- The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman SyndromeStatus unknownNCT04590183Not applicable
- A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesActive, not recruitingNCT04547049Phase 3
- Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy SubjectsCompletedNCT04542252Phase 1
- Tacrolimus as Treatment of Breast Cancer-Related LymphedemaCompletedNCT04541290Phase 1/2
- Cyclosporine A Plus Low-steroid Treatment in COVID-19 PneumoniaStatus unknownNCT04540926Phase 1/2
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- Tear Film Markers in Dry Eye SyndromeWithdrawnNCT04515329Phase 4
- Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsCompletedNCT04498741Phase 1
- PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release TacrolimusCompletedNCT04496401Phase 4
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingNCT04488081Phase 2
- Topical Steroids and Cyclosporin-A for COVID-19 KeratoconjunctivitisStatus unknownNCT04451239Not applicable
- The Effect of Cyclosporin Before Cataract SurgeryCompletedNCT04426240Phase 4
- Multitarget Therapy for Idiopathic Membranous NephropathyCompletedNCT04424862Phase 4
- Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)WithdrawnNCT04415476Phase 2
- Cyclosporine in Patients With Moderate COVID-19CompletedNCT04412785Phase 1
- Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia PatientsCompletedNCT04403321Phase 2
- Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19CompletedNCT04392531Phase 4
- Prevention of Breast Cancer-related Lymphedma With TacrolimusStatus unknownNCT04390685Phase 1/2
- Treatment of Corneal Infiltrates Secondary to Epidemic KeratoconjunctivitisCompletedNCT04376970Phase 4
- Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyStatus unknownNCT04376528Phase 4
- Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract SurgeryCompletedNCT04342988Phase 4
- Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung InjuryStatus unknownNCT04341038Phase 3
- A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.WithdrawnNCT04263519Phase 2
- Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
- Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver TransplantsCompletedNCT04237246Phase 4
- Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity EffectsActive, not recruitingNCT04207177Phase 4
- Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 DaysStatus unknownNCT04172961Phase 4
- Autologous Transplant Targeted Against Crohn'sWithdrawnNCT04154735Phase 2
- Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active MetabolitesCompletedNCT04149678Phase 1
- Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.CompletedNCT04102943Phase 4
- Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic SyndromeCompletedNCT04048161Phase 4
- Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)TerminatedNCT04039347Phase 3
- Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
- Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical StudyCompletedNCT04009525Phase 4
- Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.WithdrawnNCT03978494Phase 1
- Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal TransplantationCompletedNCT03968588Phase 4
- Tacrolimus Treatment for Refractory Autoimmune CytopeniaStatus unknownNCT03918265Phase 4
- Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren SyndromeCompletedNCT03865888Phase 3
- A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03844932Phase 2
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney TransplantsActive, not recruitingNCT03841097Phase 4
- Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis AlbaStatus unknownNCT03834935Phase 2/3
- Veloxis de Novo Kidney Transplant ECSWDStatus unknownNCT03828682Phase 4
- Envarsus XL Immunosuppression Following Liver TransplantationCompletedNCT03828058Phase 2
- Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
- Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
- A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCompletedNCT03768609Phase 1
- Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release TacrolimusCompletedNCT03760263Phase 4
- The Vienna Prograf and Endothelial Progenitor Cell Extension StudyCompletedNCT03751332Phase 4
- Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult SubjectsCompletedNCT03750383Phase 1
- A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)CompletedNCT03737708Phase 4
- Tacrolimus for Malar EdemaStatus unknownNCT03715387Phase 2/3
- Investigation of Flare and Remission in Subjects With Atopic DermatitisWithdrawnNCT03710044Phase 4
- Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive RegimenActive, not recruitingNCT03672110Phase 3
- The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye SyndromeCompletedNCT03666884Phase 4
- Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant RecipientsCompletedNCT03644485Phase 4
- Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease PatientsTerminatedNCT03640026Phase 4
- Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic DermatitisCompletedNCT03614221Phase 2
- CD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT03605927Phase 1
- Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control TrialStatus unknownNCT03603548Not applicable
- Tacrolimus Treatment for Refractory PRCAStatus unknownNCT03540472Phase 4
- A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy SubjectsCompletedNCT03466567Phase 1
- A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant PatientsCompletedNCT03465969Phase 4
- OPTImization of the Dose of tacroliMUS by Bayesian PredictionCompletedNCT03465410Phase 4
- A Novel Combined Therapy for Refractory Vernal KeratoconjunctivitisCompletedNCT03464435Phase 4
- Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant RecipientsStatus unknownNCT03438773Phase 1
- To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant RecipientsCompletedNCT03423225Phase 4
- An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male ParticipantsCompletedNCT03419910Phase 1
- Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.CompletedNCT03410654Early Phase 1
- Corneal Tear Film Imaging of the Cornea Before and After Restasis TherapyStatus unknownNCT03403023Not applicable
- Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant RecipientsTerminatedNCT03380936Early Phase 1
- Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing RegimenCompletedNCT03373227Phase 2
- Effectivness of Topical Tacrolimus Monotherapy in Patients With VitiligoStatus unknownNCT03358082Phase 1/2
- Pharmacokinetics of Tacrolimus in ChildrenCompletedNCT03347357Phase 4
- Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCTStatus unknownNCT03336632Phase 2
- Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisCompletedNCT03297502Phase 3
- Envarsus XR® in Adolescent Renal Transplant RecipientsActive, not recruitingNCT03266393Phase 4
- Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant RecipientCompletedNCT03256864Phase 4
- Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital TraumaWithdrawnNCT03240822Phase 1
- The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized VitiligoStatus unknownNCT03234673Phase 1
- Tacrolimus in Children With Henoch-Schönlein Purpura NephritisCompletedNCT03222687Phase 4
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4